As a hematologist and oncologist, Darren Sigal, MD, diagnoses and treats all types of cancers and blood disorders. His specific clinical interest is focused on gastrointestinal cancers, including pancreatic cancer, colon and rectal cancer (colorectal cancer), gastrointestinal stromal tumors (GIST tumors), cholangiocarcinoma, esophageal cancer and liver cancer. In addition, he is experienced in the diagnosis and treatment of neuroendocrine cancers, including the detection of carcinoid tumors.
In addition to his clinical practice, Dr. Sigal is an active participant and developer of unique, on-going clinical studies around pancreatic cancer, colorectal cancer and liver cancer. As an investigative sponsor with The Scripps Research Institute (TSRI) and through his affiliation with The Pancreatic Cancer Research Team (PCRT), he is able to provide his patients with access to new clinical studies for the treatment of pancreatic cancer.
Dr. Sigal believes the best treatment plans not only address the physical illness, but also place an emphasis on the patients’ goals, interests and well-being. By combining patient needs with cutting edge medical technology, he is able to achieve the best outcomes – both clinically and emotionally.
He is also a founder of the Pancreatic and Bile Duct Cancer Group, which has been recognized by the Pancreatic Cancer Action Network as a center of excellence. In addition, he is a biomarker section editor and contributor on the topic of gastrointestinal cancers for multiple scientific publications, including Personalized Medicine in Oncology.
In his spare time, he enjoys spending time with family, running and reading biographies.
Accepts new patients